Sage Therapeutics to Present at the Morgan Stanley Global Healthcare Conference
September 02 2021 - 5:30AM
Business Wire
Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical
company committed to developing novel therapies with the potential
to transform the lives of people with debilitating disorders of the
brain, announced today that the Company will participate in a
fireside chat at the Morgan Stanley Global Healthcare Conference on
September 10 at 12:30pm ET.
A live webcast of the fireside chat can be accessed on the
Investor page of Sage’s website at investor.sagerx.com. A replay of
the webcast will be available approximately two hours after the
completion of the event and will be archived for up to 30 days.
About Sage Therapeutics Sage Therapeutics is a
biopharmaceutical company committed to developing novel therapies
with the potential to transform the lives of people with
debilitating disorders of the brain. We are pursuing new pathways
with the goal of improving brain health, and our depression,
neurology and neuropsychiatry franchise programs aim to change how
brain disorders are thought about and treated. Our mission is to
make medicines that matter so people can get better, sooner. For
more information, please visit www.sagerx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210902005020/en/
Investor Contact Jeff Boyle 617-949-4256
Jeff.Boyle@sagerx.com
Media Contact Maureen L. Suda 617-949-4289
maureen.suda@sagerx.com
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Sep 2023 to Sep 2024